Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

116.73
Delayed Data
As of Mar 24
 +0.93 / +0.80%
Today’s Change
96.63
Today|||52-Week Range
177.93
+7.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.6M1.7M2.8M25.0M
 
 
 
 
 
Depreciation And Amortization105.7K442.8K1.7M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses41.0M114.5M230.2M378.7M
 
 
 
 
 
Research And Development27.9M80.3M128.2M153.9M
 
 
 
 
 
Total Operating Expenses41.1M114.9M231.9M382.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.5M-113.2M-229.2M-357.5M
 
 
 
 
 
Extraordinary Charge-28.4M-170.8M0.00-45.0M
 
 
 
 
Interest Expense On Debt--0.000.0014.2M
 
 
Other Expenses100.4K776.1K2.7M3.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-67.8M-283.2M-226.4M-412.8M
 
 
 
 
 
Net Income-67.8M-283.2M-226.4M-412.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.0M20.8M23.7M24.7M
 
 
 
 
 
Shares To Calculate EPS Diluted18.0M20.8M23.7M24.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.76-$13.63-$9.56-$16.74
 
 
 
 
 
EPS Diluted-$3.76-$13.63-$9.56-$16.74